Pernille Høyrup Hemmingsen

Title: Pernille Høyrup Hemmingsen: Innovator in Pharmaceutical Dosage Forms

Introduction

Pernille Høyrup Hemmingsen is a notable inventor based in Bagsvaerd, Denmark. He has made significant contributions to the field of pharmaceutical innovations, particularly in the development of novel dosage forms. With a total of 2 patents, Hemmingsen's work focuses on improving the delivery and efficacy of active substances in medical applications.

Latest Patents

One of Hemmingsen's latest patents is titled "Swellable dosage form comprising gellan gum - A novel dosage form." This innovative dosage form is presented in particulate form and is designed to convert into a semi-solid state upon contact with an aqueous medium. The gellan gum component allows for optimal water diffusion, enabling the dosage form to swell or gel within five minutes without the need for shear forces or mixing. The resulting texture resembles that of soft pudding, with a viscosity of at least 10,000 cps. This invention also allows for the particulate matter to be molded into specific shapes or pressed onto dispensing units, enhancing its usability.

Career Highlights

Hemmingsen is currently associated with Egalet A/S, where he continues to advance his research and development efforts in pharmaceutical formulations. His work has been instrumental in creating more effective and user-friendly medication delivery systems.

Collaborations

Throughout his career, Hemmingsen has collaborated with notable colleagues, including Daniel K Bar-Shalom and Lillian Slot. These partnerships have contributed to the success of his innovative projects and have fostered a collaborative environment for research and development.

Conclusion

Pernille Høyrup Hemmingsen is a distinguished inventor whose work in pharmaceutical dosage forms has the potential to significantly impact the industry. His innovative approaches to drug delivery systems demonstrate his commitment to enhancing patient care and medication efficacy.